Skip to Content
Merck
  • USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy.

USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy.

Scientific reports (2020-12-02)
Shao-An Wang, Ming-Jer Young, Wen-Yih Jeng, Chia-Yu Liu, Jan-Jong Hung
ABSTRACT

Bromodomain (BRD)-containing proteins are important for chromatin remodeling to regulate gene expression. In this study, we found that the deubiquitinase USP24 interacted with BRD through its C-terminus increased the levels of most BRD-containing proteins through increasing their protein stability by the removal of ubiquitin from Lys391/Lys400 of the BRD. In addition, we found that USP24 and BRG1 could regulate each other through regulating the protein stability and the transcriptional activity, respectively, of the other, suggesting that the levels of USP24 and BRG1 are regulated to form a positive feedback loop in cancer progression. Loss of the interaction motif of USP24 eliminated the ability of USP24 to stabilize BRD-containing proteins and abolished the effect of USP24 on cancer progression, including its inhibition of cancer cell proliferation and promotion of cancer cell migration, suggesting that the interaction between USP24 and the BRD is important for USP24-mediated effects on cancer progression. The targeting of BRD-containing proteins has been developed as a strategy for cancer therapy. Based on our study, targeting USP24 to inhibit the levels of BRD-containing proteins may inhibit cancer progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-BRD7 antibody, Rat monoclonal, clone BRM 2D3, purified from hybridoma cell culture
Roche
Anti-HA-Biotin, High Affinity (3F10), from rat IgG1
Sigma-Aldrich
Anti-p53 Antibody, clone BP53-12, clone BP53-12, Upstate®, from mouse